Isoflavanone

Isoflavanone

SCHEMBL72983

O=C1c2ccccc2OCC1c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoflavanone SCHEMBL15883785 1.00 CYP19A1 (1.00) CYP19A1
Isoflavanone SCHEMBL30593548 1.00 CYP19A1 (1.00) CYP19A1
Isoflavanone SCHEMBL21248250 0.91 CYP19A1 (0.94) CYP19A1
SCHEMBL13382254 0.87 CYP19A1 (0.77) CYP19A1
SCHEMBL13311871 0.87 CYP19A1 (1.00) CYP19A1
SCHEMBL29494615 0.87 CYP19A1 (1.00) CYP19A1
SCHEMBL13267880 0.87 CYP19A1 (0.77) CYP19A1
SCHEMBL2854125 0.87 CYP19A1 (1.00) CYP19A1
SCHEMBL4806201 0.87 CYP19A1 (0.77) CYP19A1
SCHEMBL13267879 0.83 CYP19A1 (0.71) CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118112145-A Fingerprint construction method and fingerprint of Xinkuanning capsules 陕西科技大学 2024-05-31 CN claimed
US-20240122894-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2024-04-18 US claimed
CN-117074587-A Fingerprint construction method and fingerprint of Xinkuanning capsules 陕西科技大学 2023-11-17 CN claimed
EP-4259614-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF National University of Singapore (SG) 2023-10-18 EP claimed
CN-116829544-A Synthesis method of flavonoid dimers and oligomers and application thereof 新加坡国立大学 2023-09-29 CN claimed
WO-2023150072-A1 COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER SINCLAIR DAVID A (US) 2023-08-10 WO claimed
CN-111574487-B Preparation method of chiral dihydroisoflavone compound and product thereof 深圳市宝安区新材料研究院 2023-02-21 CN claimed
WO-2022124994-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2022-06-16 WO claimed
CN-114431430-A Method for improving quality of marine cephalopod food 广西壮族自治区水产科学研究院 2022-05-06 CN claimed
CN-113759034-A Establishing method of ophiopogon japonicus soup substance standard 广东一方制药有限公司 2021-12-07 CN claimed
US-20040071745-A1 Admixture of carotenoids and isoflavonoids for treating cutaneous symptoms of aging SOCIETE L'OREAL S.A. (FR) 2004-04-15 US claimed
US-20040038152-A1 Method for making printing plate by inkjet deposition on positive-working media CREO SRL (CA) 2004-02-26 US claimed
WO-2004007200-A1 METHOD FOR MAKING PRINTING PLATE BY INKJET DEPOSITION ON POSITIVE-WORKING MEDIA CREO SRL (CA) 2004-01-22 WO claimed
CN-1431209-A Method for synthesizing molluscacide (Al pinumisoflavone) of pyrane isoflavone and its product INST OF MILITARY MEDICINE IN D (CN) 2003-07-23 CN claimed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO claimed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US claimed
US-20020015741-A1 Method and composition for the accelerated in vivo removal of ethanol CHEMDAN, LLC 2002-02-07 US claimed
EP-1161540-A1 GENETIC MANIPULATION OF ISOFLAVONOIDS THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2001-12-12 EP claimed
WO-2000053771-A1 GENETIC MANIPULATION OF ISOFLAVONOIDS THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2000-09-14 WO claimed
EP-0263553-A2 Method of inhibiting gene induction SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-04-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020015741-A1 Method and composition for the accelerated in vivo removal of ethanol ADH1A, ADH1C, ADH5 CYP19A1 1757/4885
US-20240122894-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF ERG28, MGAM, CTRB2 CYP19A1 875/4885
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP CYP19A1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.